The purpose of this study was to compare the hydronidone capsules (specification: 30
mg/particle, test preparation) developed by Shanghai Ruixing Gene Technology corporation with
Self reference preparation hydronidone capsule (specification: 15 mg/capsule) Differences in
the extent and rate of absorption of healthy male subjects in Fasting state in China. Through
the main pharmacokinetic parameters and relative bioavailability, whether the two are
bioequivalent, and provide a basis for the registration of the test preparation